Abbott Molecular, a genomic disease management company, engages in the development and marketing of clinical laboratory products, which provide information critical to the evaluation and management of cancer, prenatal disorders, and other genetic diseases. The Company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies.
Company Growth (employees)
Type
Public
HQ
Illinois City, US
Founded
1991
Size (employees)
75,000 (est)+2%
Website
abbott.com
Abbott was founded in 1991 and is headquartered in Illinois City, US

Key People/Management at Abbott

Miles White

Miles White

CEO
Stephen Fussell

Stephen Fussell

Executive Vice President, Human Resources

Abbott Office Locations

Abbott has offices in Illinois City, Sao Paulo, Shanghai, Beijing and in 5 other locations
Illinois City, US (HQ)
Abbott Park
Québec, CA
8401 Trans-Canada Highway, Saint-Laurent
Maidenhead, GB
Abbott House, Vanwall Business Park, Vanwall Road
Wiesbaden, DE
Abbott GmbH & Co. KG, Max-Planck-Ring 2
Seoul, KR
Samtan Bldg., 3rd Floor, 421 YoungDong-Daero, Kangnam-Ku
Tokyo, JP
3-5-27, Mita, Minato-ku
Show all (9)

Abbott Financials and Metrics

Abbott Financials

Abbott's revenue was reported to be $20.9 b in FY, 2016 which is a 2% increase from the previous period.
USD

Revenue (FY, 2016)

20.9 b

Revenue growth (FY, 2015 - FY, 2016), %

2%

Gross profit (FY, 2016)

11.8 b

Gross profit margin (FY, 2016), %

57%

Net income (FY, 2016)

1.4 b

EBIT (FY, 2016)

3.2 b

Market capitalization (17-Oct-2017)

96.3 b

Cash (31-Dec-2016)

18.6 b

EV

99.7 b
Abbott's current market capitalization is $96.3 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

21.8 b20.2 b20.4 b20.9 b

Revenue growth, %

(7%)1%2%

Cost of goods sold

10 b9.2 b8.7 b9 b

Gross profit

11.8 b11 b11.7 b11.8 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.5 b4.1 b5 b18.6 b

Accounts Receivable

4 b3.6 b3.4 b3.2 b

Inventories

2.7 b2.6 b2.6 b2.4 b

Current Assets

19.2 b15.3 b14.2 b26.8 b
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.6 b2.3 b4.4 b1.4 b

Accounts Receivable

113 m195 m171 m177 m

Inventories

(154 m)(297 m)(257 m)(98 m)

Accounts Payable

256 m225 m742 m652 m
USDY, 2016

EV/EBIT

31.3 x

EV/CFO

31.1 x

Revenue/Employee

279.9 k

Debt/Assets

0.4 x
Show all financial metrics

Abbott Operating Metrics

FY, 2014FY, 2015FY, 2016

Products

10 k1.5 k1.5 k

New Product Launches

38
Show all operating metrics

Abbott Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
AlereApril 15, 2017$5.3 b
St. Jude MedicalApril 28, 2016$25 b
Kalila MedicalApril 06, 2016
AlereFebruary 02, 2016$5.8 b

Abbott Market Value History

Abbott Job Categories

Traffic Overview of Abbott

Abbott Online and Social Media Presence

Abbott Company Life and Culture

You may also be interested in